International Clinical Trial: A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07112378) titled 'A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis' on Aug. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Care Provider).

Primary Sponsor: Regeneron Pharmaceuticals

Condition: Eosinophilic Esophagitis (EoE)

Intervention: Drug: dupilumab

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: January 13, 2026

Target Sample Size: 20

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07112378

Published...